Does TENELIGLIPTIN Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with TENELIGLIPTIN. This represents 3.5% of all adverse event reports for TENELIGLIPTIN.
6
Reports of Interstitial lung disease with TENELIGLIPTIN
3.5%
of all TENELIGLIPTIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From TENELIGLIPTIN?
Of the 6 reports, 3 (50.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENELIGLIPTIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TENELIGLIPTIN Cause?
Pemphigoid (29)
Hypoglycaemia (8)
Off label use (8)
Renal impairment (8)
Altered state of consciousness (7)
Diabetes mellitus inadequate control (7)
Diabetes mellitus (6)
Cerebral infarction (5)
Drug eruption (5)
Glycosylated haemoglobin increased (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TENELIGLIPTIN Alternatives Have Lower Interstitial lung disease Risk?
TENELIGLIPTIN vs TENIPOSIDE
TENELIGLIPTIN vs TENOFOVIR
TENELIGLIPTIN vs TENOFOVIR ALAFENAMIDE
TENELIGLIPTIN vs TENOFOVIR DISOPROXIL
TENELIGLIPTIN vs TEPLIZUMAB-MZWV